Advances in transcutaneous vaccine delivery: Do all ways lead to Rome?
Authors:
- Suzanne M. BalSuzanne M. Bal
- Zhi DingZDZhi Ding
- Elly van RietERElly van Riet
- Wim JiskootWJWim Jiskoot
- Joke A. BouwstraJBJoke A. Bouwstra
- 1 December 2010
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 148 (3) , 266-282
Abstract
No abstract availableKeywords
This publication has 260 references indexed in Scilit:
- Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid FormulationsPharmaceutical Research, 2010
- Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle ArrayPharmaceutical Research, 2010
- Microneedle-Based Vaccines2009
- Understanding human myeloid dendritic cell subsets for the rational design of novel vaccinesHuman Immunology, 2009
- Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array PretreatmentPharmaceutical Research, 2009
- Micro-scale devices for transdermal drug deliveryInternational Journal of Pharmaceutics, 2008
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- Dissolving microneedles for transdermal drug deliveryBiomaterials, 2008
- Coated microneedles for transdermal deliveryJournal of Controlled Release, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006